# ImmuniQ

**Source:** https://www.startuphub.ai/startups/immuniq
**Profile type:** Startup

> Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology.

## About

ImmuniQ is an immuno-oncology company focused on improving the efficacy of immune checkpoint inhibitors. They have developed a novel method to assess the functional activity of a patient's cancer cells, aiming to predict which patients will benefit from these treatments, thereby optimizing therapeutic outcomes.

## Key facts

- **Slug:** immuniq
- **Website:** https://www.immuniq.tech/
- **Location:** Tel Aviv, Israel
- **Founded:** 2021-06-01
- **Operating status:** Inactive
- **Sectors / tags:** Life Sciences, Oncology, Patient Care, Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Precision Medicine, Genomics

## Frequently asked

### What does ImmuniQ do?

ImmuniQ is an immuno-oncology company focused on improving the efficacy of immune checkpoint inhibitors. They have developed a novel method to assess the functional activity of a patient's cancer cells, aiming to predict which patients will benefit from these treatments, thereby optimizing therapeutic outcomes.

### Where is ImmuniQ headquartered?

ImmuniQ is headquartered in Tel Aviv, Israel.

### When was ImmuniQ founded?

ImmuniQ was founded in 2021.

### What industry does ImmuniQ operate in?

ImmuniQ operates in Life Sciences, Oncology, Patient Care, Biotech, MedTech, HealthTech.

### What is ImmuniQ's current status?

ImmuniQ's current operating status is: Inactive.

## JSON-LD

Structured data aligned with this page's `<script type="application/ld+json">` (included when the profile is server-rendered).

```json
{
  "@context": "https://schema.org",
  "@graph": [
    {
      "@type": "BreadcrumbList",
      "itemListElement": [
        {
          "@type": "ListItem",
          "position": 1,
          "name": "Home",
          "item": "https://www.startuphub.ai"
        },
        {
          "@type": "ListItem",
          "position": 2,
          "name": "Startups",
          "item": "https://www.startuphub.ai/startups"
        },
        {
          "@type": "ListItem",
          "position": 3,
          "name": "ImmuniQ",
          "item": "https://www.startuphub.ai/startups/immuniq"
        }
      ]
    },
    {
      "@type": "ProfilePage",
      "@id": "https://www.startuphub.ai/startups/immuniq#webpage",
      "url": "https://www.startuphub.ai/startups/immuniq",
      "name": "ImmuniQ - AI Startup Profile | StartupHub.ai",
      "description": "This is the official profile of ImmuniQ. ImmuniQ is a startup founded in 2021, operating in Life Sciences and Oncology. Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology. Headquartered in Tel Aviv, Israel.",
      "dateModified": "2026-07-01T09:30:43.137864+00:00",
      "mainEntity": {
        "@id": "https://www.startuphub.ai/startups/immuniq#organization"
      }
    },
    {
      "@type": "Organization",
      "@id": "https://www.startuphub.ai/startups/immuniq#organization",
      "name": "ImmuniQ",
      "url": "https://www.immuniq.tech/",
      "description": "This is the official profile of ImmuniQ. ImmuniQ is a startup founded in 2021, operating in Life Sciences and Oncology. Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology. Headquartered in Tel Aviv, Israel.",
      "sameAs": [
        "https://www.startuphub.ai/startups/immuniq"
      ],
      "foundingDate": "2021-06-01",
      "address": {
        "@type": "PostalAddress",
        "addressLocality": "Tel Aviv",
        "addressCountry": "Israel"
      },
      "knowsAbout": [
        "Life Sciences",
        "Oncology",
        "Patient Care",
        "Biotech",
        "MedTech",
        "HealthTech",
        "Drug Discovery",
        "Clinical Trials",
        "Precision Medicine",
        "Genomics"
      ]
    },
    {
      "@type": "Product",
      "@id": "https://www.startuphub.ai/startups/immuniq#profile-assessment",
      "name": "ImmuniQ - StartupHub.ai Profile Assessment",
      "url": "https://www.startuphub.ai/startups/immuniq",
      "category": "Life Sciences",
      "description": "This is the official profile of ImmuniQ. ImmuniQ is a startup founded in 2021, operating in Life Sciences and Oncology. Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology. Headquartered in Tel Aviv, Israel. Agent Readiness score: 22/100. Full audit: https://www.startuphub.ai/startups/immuniq/agent-readiness",
      "brand": {
        "@type": "Brand",
        "name": "ImmuniQ"
      },
      "review": {
        "@type": "Review",
        "author": {
          "@type": "Organization",
          "name": "StartupHub.ai"
        },
        "datePublished": "2026-07-01",
        "name": "ImmuniQ - Profile Score 54/100",
        "reviewBody": "This is the official profile of ImmuniQ. ImmuniQ is a startup founded in 2021, operating in Life Sciences and Oncology. Develops a novel method to predict patient response to immune checkpoint inhibitors in oncology. Headquartered in Tel Aviv, Israel. Agent Readiness score: 22/100. Full audit: https://www.startuphub.ai/startups/immuniq/agent-readiness",
        "reviewRating": {
          "@type": "Rating",
          "ratingValue": 54,
          "bestRating": 100,
          "worstRating": 0
        }
      }
    }
  ]
}
```